← Back to Search

Family History App for Cancer Prevention (FHAMe Trial)

N/A
Waitlist Available
Led By June Carroll, MD
Research Sponsored by University of Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
30-69 years of age
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Summary

This trial is testing a new way to record family history information that includes an app to improve use by family physicians and patients. The goal is to reduce cancer deaths and chronic disease burden.

Who is the study for?
This trial is for individuals aged 30-69 who are patients of staff physicians with an email registered in the OCEAN system. It's not suitable for pregnant individuals or those under the care of resident physicians.
What is being tested?
The trial is testing a new app-based approach to recording family health history (FHAMe Intervention) to improve its use by family doctors and patients, aiming to enhance decision-making and increase appropriate referrals for high-risk conditions.
What are the potential side effects?
Since this intervention involves using an app and improving communication rather than medication, there are no direct medical side effects. However, participants may experience increased anxiety or concern from learning about their potential genetic risks.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 30 and 69 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Changes in risk-appropriate screening based on family history
Family history of breast/ovarian/colorectal/prostate cancer
Positive family history documentation
+3 more
Secondary study objectives
Attitudes towards the FHAMe intervention
Participation rate
Recruitment rate
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
In addition to usual care, patients will be asked to answer questions about any family history through the use of a questionnaire.
Group II: Usual CareActive Control1 Intervention
Patients receive usual care, which consists of health care providers inquiring about and dealing with family history as they would in usual practice.

Find a Location

Who is running the clinical trial?

University of TorontoLead Sponsor
705 Previous Clinical Trials
1,020,924 Total Patients Enrolled
8 Trials studying Breast Cancer
2,645 Patients Enrolled for Breast Cancer
June Carroll, MDPrincipal InvestigatorMOUNT SINAI HOSPITAL

Media Library

FHAMe Intervention Clinical Trial Eligibility Overview. Trial Name: NCT04726319 — N/A
Breast Cancer Research Study Groups: Intervention, Usual Care
Breast Cancer Clinical Trial 2023: FHAMe Intervention Highlights & Side Effects. Trial Name: NCT04726319 — N/A
FHAMe Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT04726319 — N/A
~160 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top